Alzheimer's Drug May Help Mild Memory Loss

Main Category: Alzheimer's / Dementia
Also Included In: Seniors / Aging;  Neurology / Neuroscience;  Psychology / Psychiatry
Article Date: 01 Aug 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:5 stars

4.67 (3 votes)

Healthcare Prof:not yet rated


Alzheimer's disease is the end result of gradual, progressive brain aging. Positron emission technology (PET) scans of patients' brains typically reveal a decreased rate of metabolism, a hallmark of the disorder.

A small sample of adults with mild age-related memory loss was randomly assigned a daily placebo or Aricept, a drug that treats Alzheimer's symptoms. Both groups underwent PET brain scans before and after 18 months of treatment. The brains of people given Aricept showed an increased rate of metabolism and looked more normal than the brains of those who took the placebo. Both groups scored the same on memory tests, however, implying that PET scans may be more sensitive than neuropsychological tests in detecting drugs' effects.

The research suggests that the treatment of early symptoms of memory loss may protect the brain and help people with mild age-related memory impairment. The finding also shows how PET offers researchers a tool for tracking the effectiveness of drugs prescribed to treat age-related cognitive decline.

###

Dr. Gary Small, Parlow-Solomon Professor on Aging and a professor at UCLA's Semel Institute, and Dr. Daniel Silverman, UCLA head of neuronuclear imaging and associate professor of molecular and medical pharmacology, is available for interviews.

The findings were presented July 30 at the "Hot Topics" poster session of the International Conference on Alzheimer's Disease 2008, hosted by the Alzheimer's Association.

The study was funded by grants from the National Institute on Aging and private foundations. Small is a consultant to Pfizer and Eisai, which manufacture and market Aricept; and to Siemens, which manufactures and markets PET brain scanners. No commercial funding was provided.

Source: Elaine Schmidt
University of California - Los Angeles

View drug information on ARICEPT.


Article adapted by Medical News Today from original press release.
Visit our alzheimer's / dementia section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Elaine Schmidt. "Alzheimer's Drug May Help Mild Memory Loss." Medical News Today. MediLexicon, Intl., 1 Aug. 2008. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/116824.php>

APA
Elaine Schmidt. (2008, August 1). "Alzheimer's Drug May Help Mild Memory Loss." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/116824.php.

Please note: If no author information is provided, the source is cited instead.


Alzheimer's / Dementia

What is Dementia?

The word dementia comes from the Latin de meaning "apart" and mens from the genitive mentis meaning "mind". Dementia is the progressive deterioration in cognitive function - the ability to process thought (intelligence). Read more...

What Is Alzheimer's Disease?

Alzheimer's disease is a progressive neurologic disease of the brain leading to the irreversible loss of neurons and the loss of intellectual abilities, including memory and reasoning. Read more...

Most Popular Articles



Follow Our Alzheimer's News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Alzheimer's / Dementia Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »